Psoriasis Clinical Trial

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

Summary

The purpose of this study is to evaluate the effect of deucravacitinib on quality of life (QoL) in participants with plaque psoriasis in a community setting.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria

Men and women diagnosed with stable plaque psoriasis for 6 months or more. Stable psoriasis is defined as no morphology changes or significant flares of disease activity in the opinion of the investigator.
Deemed by the investigator to be a candidate for phototherapy or systemic therapy.
≥ 3% of Body Surface Area (BSA) involvement at the Screening Visit and Day 1
Dermatology Life Quality Index (DLQI) score > 5 at the Screening Visit and Day 1
Moderate-to-severe plaque psoriasis as defined by static Physician Global Assessment (s-PGA) ≥ 3 at the Screening Visit and Day 1

Exclusion Criteria:

Target Disease Exceptions:

Non-plaque psoriasis (that is, guttate, pustular, erythrodermic, palmoplantar only involvement or drug-induced psoriasis) at Screening Visit or Day 1

Other protocol-defined inclusion/exclusion criteria apply.

Study is for people with:

Psoriasis

Phase:

Phase 4

Estimated Enrollment:

174

Study ID:

NCT05701995

Recruitment Status:

Active, not recruiting

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 39 Locations for this study

See Locations Near You

Local Institution - 0006
Phoenix Arizona, 85006, United States
Local Institution - 0034
Scottsdale Arizona, 85260, United States
Local Institution - 0015
North Little Rock Arkansas, 72117, United States
Local Institution - 0004
Bakersfield California, 93309, United States
Local Institution - 0009
Sacramento California, 95815, United States
Local Institution - 0022
San Diego California, 92103, United States
Local Institution - 0030
Centennial Colorado, 80111, United States
Local Institution - 0024
Washington District of Columbia, 20016, United States
Local Institution - 0027
Brandon Florida, 33511, United States
Local Institution - 0016
Coral Gables Florida, 33134, United States
Riverchase Dermatology
Pembroke Pines Florida, 33028, United States
Local Institution - 0037
Atlanta Georgia, 30331, United States
Local Institution - 0020
Snellville Georgia, 30078, United States
Local Institution - 0007
Rolling Meadows Illinois, 60008, United States
Local Institution - 0025
Skokie Illinois, 60077, United States
Local Institution - 0036
Springfield Illinois, 62703, United States
Local Institution - 0003
Baton Rouge Louisiana, 70809, United States
Local Institution - 0018
Rockville Maryland, 20850, United States
Local Institution - 0010
Auburn Hills Michigan, 48326, United States
Local Institution - 0002
Waterford Michigan, 48328, United States
Local Institution - 0017
Las Vegas Nevada, 89148, United States
Local Institution - 0035
Reno Nevada, 89509, United States
Local Institution - 0032
New York New York, 10011, United States
Local Institution - 0013
New York New York, 10128, United States
Local Institution - 0001
Rochester New York, 14623, United States
Local Institution - 0005
Bexley Ohio, 43209, United States
Local Institution - 0012
Mayfield Heights Ohio, 44124, United States
DermDox Centers for Dermatology
Sugarloaf Pennsylvania, 18249, United States
Local Institution - 0019
Charleston South Carolina, 29407, United States
Local Institution - 0029
Cypress Texas, 77433, United States
Local Institution - 0028
Frisco Texas, 75034, United States
Local Institution - 0008
South Jordan Utah, 84095, United States
Local Institution - 0033
Springville Utah, 84663, United States
Local Institution - 0021
Bellevue Washington, 98004, United States
Local Institution - 0031
Mill Creek Washington, 98012, United States
Local Institution - 0014
Spokane Washington, 99202, United States
Local Institution - 0040
Caguas , 00727, Puerto Rico
Local Institution - 0038
Carolina , 00985, Puerto Rico
Local Institution - 0039
San Juan , 00917, Puerto Rico

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 4

Estimated Enrollment:

174

Study ID:

NCT05701995

Recruitment Status:

Active, not recruiting

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider